About 1 result found for searched term "MK-4830" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M55021 | MK-4830 | Immunology/Inflammation |
| MK-4830 is a novel, first-in-class human IgG4 monoclonal antibody targeting the myeloid-specific ILT4 (immunoglobulin-like transcript 4) receptor. MK-4830 catalyzes reprogramming of tumour-associated macrophages, relieving myelosuppression and enhancing T cell function. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
